Superior weight loss results with tirzepatide versus semaglutide - study

iStock.com/Rostislav_Sedlacek

By Jane Collingwood

Tirzepatide leads to greater weight loss than semaglutide, according to a large head-to-head US study.

The drug, sold as Mounjaro for weight loss and weight management in adults, was compared against semaglutide, which is sold as Wegovy and is currently recommended by the National Institute for Health and Care Excellence (NICE) for managing overweight and obesity.